Publication Name	World Journal of Clinical Cases
Manuscript ID	65891
Country	China

Received	2021-03-17 12:58
Peer-Review Started	2021-03-17 13:21
To Make the First Decision
Return for Revision	2021-04-04 15:37
Revised	2021-04-16 13:05
Second Decision	2021-07-02 12:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-07-02 13:34
Articles in Press	2021-07-02 13:34
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-07-10 23:55
Typeset the Manuscript	2021-08-02 00:36
Publish the Manuscript Online	2021-08-05 14:37

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	Theory and reality of antivirals against SARS-CoV-2
Manuscript Source	Invited Manuscript
All Author List	Bo Zhao, Teng-Fei Yang and Rui Zheng
ORCID	Author(s) ORCID Number Bo Zhao http://orcid.org/0000-0001-8680-5288 Teng-Fei Yang http://orcid.org/0000-0002-6083-6139 Rui Zheng http://orcid.org/0000-0001-5906-0081
Funding Agency and Grant Number	Funding Agency Grant Number 345 Talent Project of Shengjing Hospital of China Medical University
Corresponding Author	Rui Zheng, MD, PhD, Chief Physician, Deputy Director, Doctor, Professor, Teacher, Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, Liaoning Province, China. zhengr@sj-hospital.org
Key Words	SARS-CoV-2; Antivirals; Efficacy; Safety; Middle East respiratory syndrome coronavirus
Core Tip	This paper reviews the pharmacology and application of interferon, lopinavir/ritonavir, ribavirin, chloroquine, arbidol, favipiravir, remdesivir and thymosin α1. The actual effect of these drugs remains controversial. Meanwhile, the efficacy and safety of these drugs for patients with coronavirus disease 2019 still need to be explored.
Publish Date	2021-08-05 14:37
Citation	Zhao B, Yang TF, Zheng R. Theory and reality of antivirals against SARS-CoV-2. World J Clin Cases 2021; 9(23): 6663-6673
URL	https://www.wjgnet.com/2307-8960/full/v9/i23/6663.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i23.6663

Full Article (PDF)	WJCC-9-6663.pdf
Full Article (Word)	WJCC-9-6663.docx
Manuscript File	65891_Auto_Edited-ZMG_WangTQ.docx
Answering Reviewers	65891-Answering reviewers.pdf
Audio Core Tip	65891-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	65891-Conflict-of-interest statement.pdf
Copyright License Agreement	65891-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	65891-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	65891-Language certificate.pdf
Peer-review Report	65891-Peer-review(s).pdf
Scientific Misconduct Check	65891-Bing-Liu M-1.png
Scientific Misconduct Check	65891-Bing-Yan JP-2.jpg
Scientific Misconduct Check	65891-Scientific misconduct check.pdf
Scientific Editor Work List	65891-Scientific editor work list.pdf